Indication
Nosocomial pneumonia due to Klebsiella pneumoniae
Nosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission. Read more about Nosocomial pneumonia due to Klebsiella pneumoniae
50 drugs 46 manufacturers
Drugs that treat it
Common Nosocomial pneumonia due to Klebsiella pneumoniae therapies.
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission.
It predominantly affects hospitalized individuals in intensive care units, mechanically ventilated patients, the elderly, and immunocompromised hosts with chronic underlying conditions.
Pathophysiologically, the organism colonizes the oropharynx or medical devices and is microaspirated into the lower respiratory tract, where virulence determinants—such as a thick polysaccharide capsule and endotoxins—promote parenchymal inflammation, extensive tissue necrosis, and purulent alveolar exudation.
Clinically, it manifests with fever, productive cough with purulent sputum, dyspnea, leukocytosis, and focal pulmonary infiltrates on imaging, frequently complicated by cavitation, abscess formation, or multidrug resistance.
- nih.gov
Nosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission It predominantly affects hospitalized individuals in intensive care units, mechanically ventilated patients, the elderly, and immunocompromised hosts with chronic underlying conditions Clinically, it manifests with fever, productive cough with purulent spu...
- nih.gov
Nosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission Pathophysiologically, the organism colonizes the oropharynx or medical devices and is microaspirated into the lower respiratory tract, where virulence determinants—such as a thick polysaccharide capsule and endotoxins—promote parenchymal inflammation, exte...
- regulations.gov
It predominantly affects hospitalized individuals in intensive care units, mechanically ventilated patients, the elderly, and immunocompromised hosts with chronic underlying conditions
- nih.gov
Pathophysiologically, the organism colonizes the oropharynx or medical devices and is microaspirated into the lower respiratory tract, where virulence determinants—such as a thick polysaccharide capsule and endotoxins—promote parenchymal inflammation, extensive tissue necrosis, and purulent alveolar exudation
- cdc.gov
Pathophysiologically, the organism colonizes the oropharynx or medical devices and is microaspirated into the lower respiratory tract, where virulence determinants—such as a thick polysaccharide capsule and endotoxins—promote parenchymal inflammation, extensive tissue necrosis, and purulent alveolar exudation
- nih.gov
Clinically, it manifests with fever, productive cough with purulent sputum, dyspnea, leukocytosis, and focal pulmonary infiltrates on imaging, frequently complicated by cavitation, abscess formation, or multidrug resistance
Personalize your experience
Follow Nosocomial pneumonia due to Klebsiella pneumoniae and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.